Presentations & Publications

July 17-19, 2020
AT-007: Development of an Oral Treatment for Patients with Galactosemia
Presented by Shoshana Shendelman, PhD, CEO and Founder, Applied Therapeutics
Galactosemia Foundation Conference
ACTION-Galactosemia: Clinical Experience with Adult Galactosemia Patients and Path Forward
Presented by Riccardo Perfetti, MD, PhD, Chief Medical Officer, Applied Therapeutics
Galactosemia Foundation Conference
ACTION-Galactosemia Kids: Pediatric Study of AT-007 in Children with Galactosemia
Presented by Shoshana Shendelman, PhD, CEO and Founder, Applied Therapeutics
Galactosemia Foundation Conference
April 28, 2020
Applied Therapeutics Galactosemia Educational Symposium
Presented by Dr. Shoshana Shendelman, PhD & Dr. Riccardo Perfetti, MD, PhD
Moderated by Dr. Eva-Kozicz, MD, PhD
16th Global Cardio Vascular Clinical Trialists (CVCT) Forum
Washington, D.C.
American Society of Human Genetics (ASHG) 2019 Annual Meeting
Houston, Texas
55th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Barcelona, Spain
Heart Failure Society of America (HFSA) 23rd Annual Scientific Meeting
Philadelphia, PA

October 15-16, 2018
A Novel Investigational Treatment In Preclinical Development For Galactosemia

NORD Rare Summit 2018
Washington, D.C.